Inhibition of Human Immunodeficiency Virus Type 1 Entry in Cells Expressing gp41-Derived Peptides

As the limitations of antiretroviral drug therapy, such as toxicity and resistance, become evident, interest in alternative therapeutic approaches for human immunodeficiency virus (HIV) infection is growing. We developed the first gene therapeutic strategy targeting entry of a broad range of HIV typ...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Virol
Main Authors: Egelhofer, Marc, Brandenburg, Gunda, Martinius, Holger, Schult-Dietrich, Patricia, Melikyan, Gregory, Kunert, Renate, Baum, Christopher, Choi, Ingrid, Alexandrov, Alexander, von Laer, Dorothee
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 2004
Teme:
Vaccines and Antiviral Agents
Online dostop:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC368739/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14694088/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.78.2.568-575.2004
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki